Correlation between 25(OH)D and HbA1c with Diabetic Nephropathy
DOI:
10.29303/jppipa.v11i10.12692Published:
2025-10-25Downloads
Abstract
Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia due to impaired insulin secretion or action. DM patients may develop diabetic nephropathy (ND), marked by decreased glomerular filtration rate (eGFR), also influenced by hypertension. Vitamin D in its active form, 25-hydroxyvitamin D (25(OH)D), regulates insulin secretion and supports pancreatic beta cell survival. The relationship between 25(OH)D, HbA1c, and ND needs evaluation to predict ND earlier. To analyze the correlation between 25(OH)D and HbA1c levels with ND measured by eGFR in DM patients at Diponegoro National Hospital, Semarang. A cross-sectional study of 82 DM patients. 25(OH)D levels were measured by Fluorescent Immunoassay (FIA) and HbA1c by High-Performance Liquid Chromatography (HPLC). eGFR was calculated from creatinine using the CKD-EPI formula. Data analysis used Pearson and regression tests (p<0.25). A weak positive correlation was found between HbA1c and eGFR (p=0.002, r=0.307) and a very weak negative correlation between 25(OH)D and eGFR (p=0.147, r=-0.117). The combined influence of HbA1c, 25(OH)D, and blood pressure yielded R²=0.21. Higher HbA1c increases eGFR, while lower 25(OH)D also associates with higher eGFR. eGFR is influenced by HbA1c, 25(OH)D, and blood pressure by 21%, with other factors explaining the remainder.
Keywords:
25(OH)D, Diabetic nephropathy, eGFR, HbA1cReferences
Adjei, S. K., Adjei, P., & Nkrumah, P. A. (2025). Poor Glycemic Control and Its Predictors Among Type 2 Diabetes Patients: Insights From a Single‐Centre Retrospective Study in Ghana. Health Science Reports, 8(3). https://doi.org/10.1002/hsr2.70558
Agarwal, R. (2021). Pathogenesis of Diabetic Nephropathy. ADA Clinical Compendia, 2021(1), 2–7. https://doi.org/10.2337/db20211-2
Ajabshir, S., Asif, A., & Nayer, A. (2014). The effects of vitamin D on the renin-angiotensin system. Journal of Nephropathology, 3(2), 41–43. https://doi.org/10.12860/jnp.2014.09
Akazawa, S., Sadashima, E., Sera, Y., & Koga, N. (2022). Decline in the estimated glomerular filtration rate (eGFR) following metabolic control and its relationship with baseline eGFR in type 2 diabetes with microalbuminuria or macroalbuminuria. Diabetology International, 13(1), 148–159. https://doi.org/10.1007/s13340-021-00517-2
Ali, M. I., Fawaz, L. A., Sedik, E. E., Nour, Z. A., & Elsayed, R. M. (2019). Vitamin D status in diabetic patients (type 2) and its relation to glycemic control & diabetic nephropathy. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(3), 1971–1973. https://doi.org/10.1016/j.dsx.2019.04.040
Alsalemi, N., Sadowski, C. A., Elftouh, N., Louis, M., Kilpatrick, K., Houle, S. K. D., & Lafrance, J.-P. (2022). The effect of renin–angiotensin–aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials. BMC Nephrology, 23(1), 161. https://doi.org/10.1186/s12882-022-02763-1
Alwakeel, J. S., Isnani, A. C., Alsuwaida, A., AlHarbi, A., Shaikh, S. A., AlMohaya, S., & Al Ghonaim, M. (2011). Factors affecting the progression of diabetic nephropathy and its complications: A single-center experience in Saudi Arabia. Annals of Saudi Medicine, 31(3), 236–242. https://doi.org/10.4103/0256-4947.81528
Alzahrani, S. H., Baig, M., Yaghmour, K. A., & Al Muammar, S. (2024). Determinants of Vitamin D deficiency among type 2 diabetes mellitus patients: A retrospective study. Medicine, 103(8), e37291. https://doi.org/10.1097/MD.0000000000037291
Anyanwu, A., Olopade, O., Onung, S., Odeniyi, I., Coker, H., Fasanmade, O., & Ohwovoriole, A. (2020). Serum Vitamin D Levels in Persons with Type 2 Diabetes Mellitus in Lagos, Nigeria. International Journal of Diabetes and Clinical Research, 7(4). https://doi.org/10.23937/2377-3634/1410133
Arnold, F., Kappes, J., Rottmann, F. A., Westermann, L., & Welte, T. (2024). HbA1c‐dependent projection of long‐term renal outcomes. Journal of Internal Medicine, 295(2), 206–215. https://doi.org/10.1111/joim.13736
Baek, J. H., Lee, W. J., Lee, B.-W., Kim, S. K., Kim, G., Jin, S.-M., & Kim, J. H. (2021). Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus. Diabetes & Metabolism Journal, 45(1), 46–54. https://doi.org/10.4093/dmj.2019.0134
Bakris, G. L. (2003). Effects of Blood Pressure Level on Progression of Diabetic Nephropathy<subtitle>Results From the RENAAL Study</subtitle> Archives of Internal Medicine, 163(13), 1555. https://doi.org/10.1001/archinte.163.13.1555
Blanton, D., Han, Z., Bierschenk, L., Linga-Reddy, M. V. P., Wang, H., Clare-Salzler, M., Haller, M., Schatz, D., Myhr, C., She, J.-X., Wasserfall, C., & Atkinson, M. (2011). Reduced Serum Vitamin D–Binding Protein Levels Are Associated With Type 1 Diabetes. Diabetes, 60(10), 2566–2570. https://doi.org/10.2337/db11-0576
Chawla, T. (2010). Role of the renin angiotensin system in diabetic nephropathy. World Journal of Diabetes, 1(5), 141. https://doi.org/10.4239/wjd.v1.i5.141
Chen, H., Ni, L., & Wu, X. (2023). Performance of urinary vitamin D-binding protein in diabetic kidney disease: a meta-analysis. Renal Failure, 45(2). https://doi.org/10.1080/0886022X.2023.2256415
de Oliveira e Silva Ullmann, T., Ramalho, B. J., Laurindo, L. F., Tofano, R. J., Rubira, C. J., Guiguer, E. L., Barbalho, S. M., Flato, U. A. P., Sloan, K. P., & Araujo, A. C. (2023). Effects of Vitamin D Supplementation in Diabetic Kidney Disease: A Systematic Review. Journal of Renal Nutrition, 33(5), 618–628. https://doi.org/10.1053/j.jrn.2023.05.006
Dean, Y. E., Elawady, S. S., Shi, W., Salem, A. A., Chotwatanapong, A., Ashraf, H., Reddi, T., Dundi, P. O. R., Habash, W. Y., Habash, M. Y., Ahmed, S., Samir, H. M., Elsayed, A., Arora, A., Arora, A., Elsayed, A., Mady, T., Tanas, Y., Hazimeh, Y., … Aiash, H. (2023). Progression of diabetic nephropathy and vitamin D serum levels: A pooled analysis of 7722 patients. Endocrinology, Diabetes & Metabolism, 6(6). https://doi.org/10.1002/edm2.453
Delrue, C., Speeckaert, R., Delanghe, J. R., & Speeckaert, M. M. (2022a). The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach. International Journal of Molecular Sciences, 23(2), 807. https://doi.org/10.3390/ijms23020807
Delrue, C., Speeckaert, R., Delanghe, J. R., & Speeckaert, M. M. (2022b). The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach. International Journal of Molecular Sciences, 23(2), 807. https://doi.org/10.3390/ijms23020807
Derakhshanian, H., Djazayery, A., Javanbakht, M. H., Eshraghian, M. R., Mirshafiey, A., Zarei, M., Alvandi, E., Djalali, E., & Djalali, M. (2019). The Effect of Vitamin D on Cellular Pathways of Diabetic Nephropathy. Reports of Biochemistry & Molecular Biology, 7(2), 217–222. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6374056/
Derakhshanian, H., Shab-Bidar, S., Speakman, J. R., Nadimi, H., & Djafarian, K. (2015). Vitamin D and diabetic nephropathy: A systematic review and meta-analysis. Nutrition, 31(10), 1189–1194. https://doi.org/10.1016/j.nut.2015.04.009
Elendu, C., John Okah, M., Fiemotongha, K. D. J., Adeyemo, B. I., Bassey, B. N., Omeludike, E. K., & Obidigbo, B. (2023). Comprehensive advancements in the prevention and treatment of diabetic nephropathy: A narrative review. Medicine, 102(40), e35397. https://doi.org/10.1097/MD.0000000000035397
Emini Sadiku, M. (2025). Impact of vitamin D and vitamin D receptor activator in diabetic nephropathy. Frontiers in Clinical Diabetes and Healthcare, 6. https://doi.org/10.3389/fcdhc.2025.1537336
Fawzy, M. S., & Abu AlSel, B. T. (2018). Assessment of Vitamin D-Binding Protein and Early Prediction of Nephropathy in Type 2 Saudi Diabetic Patients. Journal of Diabetes Research, 2018, 1–13. https://doi.org/10.1155/2018/8517929
Felício, J. S., de Rider Britto, H. A., Cortez, P. C., de Souza Resende, F., de Lemos, M. N., de Moraes, L. V., de Aquino, V. T., de Souza Parente, F., de Queiroz, N. N. M., Abrahão Neto, J. F., de Alcântara, A. L., da Silva, W. M., de Souza Neto, N. J. K., Freire Piani, P. P., de Souza, Í. J. A., Silva, L. de S. D., de Oliveira, M. C. N. I., Said, N. M., Nascimento de Lemos, G., … Felício, K. M. (2021). Association Between 25(OH)Vitamin D, HbA1c and Albuminuria in Diabetes Mellitus: Data From a Population-Based Study (VIDAMAZON). Frontiers in Endocrinology, 12. https://doi.org/10.3389/fendo.2021.723502
Forman, J. P., Williams, J. S., & Fisher, N. D. L. (2010). Plasma 25-Hydroxyvitamin D and Regulation of the Renin-Angiotensin System in Humans. Hypertension, 55(5), 1283–1288. https://doi.org/10.1161/HYPERTENSIONAHA.109.148619
Gomes, M. B., Tang, F., Chen, H., Cid-Ruzafa, J., Fenici, P., Khunti, K., Rathmann, W., Shestakova, M. V., Surmont, F., Watada, H., Medina, J., Shimomura, I., Saraiva, G. L., Cooper, A., & Nicolucci, A. (2022). Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.831676
Grassi, G., Mancia, G., & Nilsson, P. M. (2016). Specific Blood Pressure Targets for Patients With Diabetic Nephropathy? Diabetes Care, 39(Supplement_2), S228–S233. https://doi.org/10.2337/dcS15-3020
Habte-Asres, H. H., Murrells, T., Nitsch, D., Wheeler, D. C., & Forbes, A. (2022). Glycaemic variability and progression of chronic kidney disease in people with diabetes and comorbid kidney disease: Retrospective cohort study. Diabetes Research and Clinical Practice, 193, 110117. https://doi.org/10.1016/j.diabres.2022.110117
Hata, S., Ushigome, E., Hosomi, Y., Yoshimura, T., Takegami, M., Kitagawa, N., Tanaka, T., Hasegawa, G., Ohnishi, M., Tsunoda, S., Ushigome, H., Asano, M., Hamaguchi, M., Yamazaki, M., & Fukui, M. (2023). Impact of continued high blood pressure on the progression of diabetic nephropathy after 10 years: KAMOGAWA-HBP study. Hypertension Research, 46(3), 565–574. https://doi.org/10.1038/s41440-022-01136-3
Hu, W., Hao, H., Yu, W., Wu, X., & Zhou, H. (2015). Association of elevated glycosylated hemoglobin A1c with hyperfiltration in a middle-aged and elderly Chinese population with prediabetes or newly diagnosed diabetes: a cross-sectional study. BMC Endocrine Disorders, 15(1), 47. https://doi.org/10.1186/s12902-015-0043-0
Huang, H.-Y., Lin, T.-W., Hong, Z.-X., & Lim, L.-M. (2023). Vitamin D and Diabetic Kidney Disease. International Journal of Molecular Sciences, 24(4), 3751. https://doi.org/10.3390/ijms24043751
Indra, T. A., Lydia, A., Purnamasari, D., & Setiati, S. (2017). Asosiasi antara Status Vitamin D 25(Oh)D dengan Albuminuria pada Pasien Diabetes Melitus Tipe 2. Jurnal Penyakit Dalam Indonesia, 4(1), 16. https://doi.org/10.7454/jpdi.v4i1.108
Jia, J., Tao, X., Tian, Z., Liu, J., Ye, X., & Zhan, Y. (2022). Vitamin D receptor deficiency increases systolic blood pressure by upregulating the renin angiotensin system and autophagy. Experimental and Therapeutic Medicine, 23(4), 314. https://doi.org/10.3892/etm.2022.11243
Kamruzzaman, M., Horowitz, M., Rahman, M. S., Deshmukh, H., Jones, K. L., & Marathe, C. S. (2025). Glycemic control is worse in rural compared to urban type 2 diabetes in Bangladesh, irrespective of food security status. Journal of Diabetes Investigation, 16(6), 1112–1118. https://doi.org/10.1111/jdi.70015
Kitagawa, N., Ushigome, E., Kitagawa, N., Ushigome, H., Yokota, I., Nakanishi, N., Hamaguchi, M., Asano, M., Yamazaki, M., & Fukui, M. (2022). Diabetic nephropathy ameliorated in patients with normal home blood pressure compared to those with isolated high home systolic blood pressure: A 5-year prospective cohort study among patients with type 2 diabetes mellitus. Diabetes and Vascular Disease Research, 19(3). https://doi.org/10.1177/14791641221098193
Koroshi, A., & Idrizi, A. (2011). Renoprotective effects of Vitamin D and renin-angiotensin system. Hippokratia, 15(4), 308–311. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC3876844/
Lee, C.-L., Chen, C.-H., Wu, M.-J., & Tsai, S.-F. (2020). The variability of glycated hemoglobin is associated with renal function decline in patients with type 2 diabetes. Therapeutic Advances in Chronic Disease, 11. https://doi.org/10.1177/2040622319898370
Lee, C.-L., Li, T.-C., Lin, S.-Y., Wang, J.-S., Lee, I.-T., Tseng, L.-N., Song, Y.-M., Tsai, S.-F., & Sheu, W. H.-H. (2013). Dynamic and Dual Effects of Glycated Hemoglobin on Estimated Glomerular Filtration Rate in Type 2 Diabetic Outpatients. American Journal of Nephrology, 38(1), 19–26. https://doi.org/10.1159/000351803
Lee, M.-Y., Huang, J.-C., Chen, S.-C., Chiou, H.-Y. C., & Wu, P.-Y. (2018). Association of HbA1C Variability and Renal Progression in Patients with Type 2 Diabetes with Chronic Kidney Disease Stages 3–4. International Journal of Molecular Sciences, 19(12), 4116. https://doi.org/10.3390/ijms19124116
Leehey, D. J., Kramer, H. J., Daoud, T. M., Chatha, M. P., & Isreb, M. A. (2005a). Progression of kidney disease in type 2 diabetes – beyond blood pressure control: an observational study. BMC Nephrology, 6(1), 8. https://doi.org/10.1186/1471-2369-6-8
Leoncini, G., Viazzi, F., De Cosmo, S., Russo, G., Fioretto, P., & Pontremoli, R. (2020). Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations. Journal of Nephrology, 33(5), 949–963. https://doi.org/10.1007/s40620-020-00803-3
Li, M., & Li, Y. (2020). Prevalence and influencing factors of vitamin D deficiency in chronic kidney disease: A cross-sectional study. Int. Journal of Clinical Pharmacology and Therapeutics, 58(11), 595–600. https://doi.org/10.5414/CP203737
López-Revuelta, K., Galdo, P. P., Stanescu, R., Parejo, L., Guerrero, C., & Pérez-Fernández, E. (2014). Silent diabetic nephropathy. World Journal of Nephrology, 3(1), 6–15. https://doi.org/10.5527/wjn.v3.i1.6
MacIsaac, R. J., Jerums, G., & Ekinci, E. I. (2017). Effects of glycaemic management on diabetic kidney disease. World Journal of Diabetes, 8(5), 172. https://doi.org/10.4239/wjd.v8.i5.172
Maghbooli, Z., Ebrahimi Meimand, S., Malek Hosseini, A.-A., & Shirvani, A. (2022). Alterations in circulating levels of vitamin D binding protein, total and bioavailability of vitamin D in diabetic retinopathy patients. BMC Endocrine Disorders, 22(1), 169. https://doi.org/10.1186/s12902-022-01084-6
Mehrabbeik, A., Tofighi, D., Khalilzadeh, S. H., Azizi, R., Namiranian, N., & Azad, F. (2024). Factors Associated with Achieving HbA1c Targets in Patients with Type 2 Diabetes. Jundishapur Journal of Chronic Disease Care, 13(4). https://doi.org/10.5812/jjcdc-147903
Molina, P. E. (2023). Parathyroid gland and Ca2+ and PO4- regulation (6th ed). McGraw Hill.
Momeni, A., Mirhosseini, M., Kabiri, M., & Kheiri, S. (2016). Impact of vitamin D therapy on decreasing of proteinuria in type 2 diabetic patients. Journal of Nephropathology, 6(1), 10–14. https://doi.org/10.15171/jnp.2017.03
Natesan, V., & Kim, S.-J. (2021). Diabetic Nephropathy - a Review of Risk Factors, Progression, Mechanism, and Dietary Management. Biomolecules & Therapeutics, 29(4), 365–372. https://doi.org/10.4062/biomolther.2020.204
Nguyen, K. A., Daniel, M., Zhao, Y., Sekgala, D., Kallakuri, S., Hill, J., Joshi, R., Kengne, A. P., & Peer, N. (2025). Association of depression with glycaemic control in people living with diabetes in low- and middle-income countries: a systematic review and meta-analysis. BMJ Global Health, 10(7), e018939. https://doi.org/10.1136/bmjgh-2025-018939
Okada, H., Fukui, M., Tanaka, M., Matsumoto, S., Iwase, H., Kobayashi, K., Asano, M., Yamazaki, M., Hasegawa, G., & Nakamura, N. (2013). A difference in systolic blood pressure between arms is a novel predictor of the development and progression of diabetic nephropathy in patients with type 2 diabetes. Atherosclerosis, 230(2), 198–201. https://doi.org/10.1016/j.atherosclerosis.2013.07.040
Okawa, Y., Suzuki, E., Mitsuhashi, T., Tsuda, T., & Yorifuji, T. (2023). A population-based longitudinal study on glycated hemoglobin levels and new-onset chronic kidney disease among non-diabetic Japanese adults. Scientific Reports, 13(1), 13770. https://doi.org/10.1038/s41598-023-40300-8
Papatheodorou, K., Banach, M., Bekiari, E., Rizzo, M., & Edmonds, M. (2018). Complications of Diabetes 2017. Journal of Diabetes Research, 2018, 1–4. https://doi.org/10.1155/2018/3086167
Park, C. H., Hong, S. J., Kim, S. G., Shin, S. J., Kim, D. K., Lee, J. P., Han, S. Y., Lee, S., Won, J. C., Kang, Y. S., Park, J., Han, B.-G., Na, K.-R., Hur, K. Y., Kim, Y.-J., Park, S., & Yoo, T.-H. (2024). Blood pressure control in diabetic kidney disease: a post-hoc analysis of the FANTASTIC trial. Clinical Hypertension, 30(1). https://doi.org/10.1186/s40885-024-00280-x
Pinky, A. A., Zulfian, Z., Syuhada, S., & Pebriani, U. (2023). Hubungan Kadar HbA1c ≥7% dengan Kadar Ureum dan Kreatinin pada Penderita Diabetes Mellitus Tipe 2 di Rumah Sakit Pertamina Bintang Amin Bandar Lampung. Jurnal Ilmu Kedokteran Dan Kesehatan, 10(10), 3032–3038. Retrieved from https://shorturl.at/jjZjq
Qaz, M., Sawaf, H., Ismail, J., Qazi, H., & Vachharajani, T. (2022). Pathophysiology of Diabetic Kidney Disease. EMJ Nephrology, 102–113. https://doi.org/10.33590/emjnephrol/22-00060
Radcliffe, N. J., Seah, J., Clarke, M., MacIsaac, R. J., Jerums, G., & Ekinci, E. I. (2017). Clinical predictive factors in diabetic kidney disease progression. Journal of Diabetes Investigation, 8(1), 6–18. https://doi.org/10.1111/jdi.12533
Rout P, J. I. (2025). Diabetic Nephropathy. StatPearls Publishing.
Ruggenenti, P., Cravedi, P., & Remuzzi, G. (2010). The RAAS in the pathogenesis and treatment of diabetic nephropathy. Nature Reviews Nephrology, 6(6), 319–330. https://doi.org/10.1038/nrneph.2010.58
Santoro, D., Caccamo, D., Lucisano, S., Buemi, M., Sebekova, K., Teta, D., & De Nicola, L. (2015). Interplay of Vitamin D, Erythropoiesis, and the Renin-Angiotensin System. BioMed Research International, 2015, 1–11. https://doi.org/10.1155/2015/145828
Semnani-Azad, Z., Wang, W. Z. N., Cole, D. E. C., Johnston, L. W., Wong, B. Y. L., Fu, L., Retnakaran, R., Harris, S. B., & Hanley, A. J. (2024). Urinary Vitamin D Binding Protein: A Marker of Kidney Tubular Dysfunction in Patients at Risk for Type 2 Diabetes. Journal of the Endocrine Society, 8(3). https://doi.org/10.1210/jendso/bvae014
Souza, C. S., Deluque, A. L., Oliveira, B. M., Maciel, A. L. D., Giovanini, C., Boer, P. A., de Paula, F. J. A., Costa, R. S., Franscecato, H. D. C., de Almeida, L. F., & Coimbra, T. M. (2023). Vitamin D deficiency contributes to the diabetic kidney disease progression via increase ZEB1/ZEB2 expressions. Nutrition & Diabetes, 13(1), 9. https://doi.org/10.1038/s41387-023-00238-2
Sternlicht, H., & Bakris, G. L. (2016). Management of Hypertension in Diabetic Nephropathy: How Low Should We Go? Blood Purification, 41(1–3), 139–143. https://doi.org/10.1159/000441264
Stojceva-Taneva, O., Selim, G., Stojkovski, L., & Ivanovski, N. (2007). Hypertension and progression of nephropathy in diabetic and non-diabetic chronic kidney disease patients. Hippokratia, 11(2), 72–76. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC2464275/
Taderegew, M. M., Woldeamanuel, G. G., Wondie, A., Getawey, A., Abegaz, A. N., & Adane, F. (2023). Vitamin D deficiency and its associated factors among patients with type 2 diabetes mellitus: a systematic review and meta-analysis. BMJ Open, 13(10), e075607. https://doi.org/10.1136/bmjopen-2023-075607
Tarawifa, S., Bonar, S. B., & Sitepu, I. (2020). Hubungan Kadar Hba1c Dengan Resiko Nefropati Diabetikum Pada Pasien DM Tipe 2 Di RSUD H. Abdul Manap Kota Jambi. Jurnal Ilmu Kedokteran Dan Kesehatan, 7(2). https://doi.org/10.33024/jikk.v7i2.2755
Tian, X.-Q., Zhao, L.-M., Ge, J.-P., Zhang, Y., & Xu, Y.-C. (2014). Elevated urinary level of vitamin D-binding protein as a novel biomarker for diabetic nephropathy. Experimental and Therapeutic Medicine, 7(2), 411–416. https://doi.org/10.3892/etm.2013.1426
Tomlinson, J. W., Owen, K. R., & Close, C. F. (2003). Treating Hypertension in Diabetic Nephropathy. Diabetes Care, 26(6), 1802–1805. https://doi.org/10.2337/diacare.26.6.1802
Troya, M.-I., Bonet, J., Salinas, I., Torres, F., Bonal, J., Sanmartí, A., & Romero, R. (2016). Early intensive treatment improves outcomes in patients with glomerular hyperfiltration and type 2 diabetes. Medicina Clínica (English Edition), 146(2), 55–60. https://doi.org/10.1016/j.medcle.2015.05.048
Truscello, L., Nobre, D., Sabaratnam, V., Bonny, O., Wuerzner, G., Burnier, M., Fakhouri, F., Pruijm, M., & Zanchi, A. (2023). Blood pressure and vascular determinants of glomerular filtration rate decline in diabetic kidney disease. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1230227
Van Buren, P. N., & Toto, R. (2011). Hypertension in Diabetic Nephropathy: Epidemiology, Mechanisms, and Management. Advances in Chronic Kidney Disease, 18(1), 28–41. https://doi.org/10.1053/j.ackd.2010.10.003
Vijay, G. S., Ghonge, S., Vajjala, S. M., & Palal, D. (2023). Prevalence of Vitamin D Deficiency in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study. Cureus. https://doi.org/10.7759/cureus.38952
WHO. (2023). Diabetes. Retrieved from https://www.who.int/news-room/fact-sheets/detail/diabetes.
Xiao, X., Wang, Y., Hou, Y., Han, F., Ren, J., & Hu, Z. (2016). Vitamin D deficiency and related risk factors in patients with diabetic nephropathy. Journal of International Medical Research, 44(3), 673–684. https://doi.org/10.1177/0300060515593765
Xu, J., Xue, Y., Chen, Q., Han, X., Cai, M., Tian, J., Jin, S., & Lu, H. (2022). Identifying Distinct Risk Thresholds of Glycated Hemoglobin and Systolic Blood Pressure for Rapid Albuminuria Progression in Type 2 Diabetes from NHANES (1999–2018). Frontiers in Medicine, 9. https://doi.org/10.3389/fmed.2022.928825
Xuan, S., Jin, Z., Zhe, W., Huai-en, B., Chun-ying, T., Dong-jun, W., Yuan-yuan, G., & Hong-wu, W. (2023). A systematic review and meta-analysis of randomized control trials of vitamin D supplementation in diabetic nephropathy. International Journal of Diabetes in Developing Countries, 43(1), 4–11. https://doi.org/10.1007/s13410-022-01108-w
Yokoyama, H., Okudaira, M., Otani, T., Watanabe, C., Takaike, H., Miuira, J., Yamada, H., Mutou, K., Satou, A., Uchigata, Y., & Iwamoto, Y. (1998). High Incidence of Diabetic Nephropathy in Early-Onset Japanese NIDDM Patients: Risk analysis. Diabetes Care, 21(7), 1080–1085. https://doi.org/10.2337/diacare.21.7.1080
Zhao, M., Cao, Y., & Ma, L. (2025). New insights in the treatment of DKD: recent advances and future prospects. BMC Nephrology, 26(1), 72. https://doi.org/10.1186/s12882-025-03953-3
Zhu, X., Zhou, Y., Hong, S., Xue, Y., & Cui, Y. (2021). Correlation between Serum Bone Turnover Markers and Estimated Glomerular Filtration Rate in Chinese Patients with Diabetes. Disease Markers, 2021, 1–5. https://doi.org/10.1155/2021/6731218
Zhu, Y., Jun, M., Fletcher, R. A., Arnott, C., Neuen, B. L., & Kotwal, S. S. (2025). Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial. Diabetes, Obesity and Metabolism, 27(6), 3531–3535. https://doi.org/10.1111/dom.16363
License
Copyright (c) 2025 Meita Hendrianingtyas, Dewi Paramita Yuniarahmi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Jurnal Penelitian Pendidikan IPA, agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Jurnal Penelitian Pendidikan IPA.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
